Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-875 vs placebo in type 2 diabetes mellitus (Phase 3, China)
CTR20130368Phase 3Suspended
- Sponsor
- Takeda
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Apr 2014; status: suspended.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20130368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130368.